Latest / Decera Clinical Education Oncology Podcast
Clinical Highlights: Oral SERDs for Patients With HR+/HER2- ESR1-Mutated Advanced Breast Cancer
In this episode, listen to Virginia Kaklamani, MD, DSc; Erica L. Mayer, MD, MPH; and Laura M. Spring, MD, share their clinical insights and takeaways from a live symposium, including from key abstracts presented at the 2024 San Antonio Breast Cancer Symposium:
Estrogen receptor mutations in patients With HR-positive/HER2-negative advanced breast cancer
Current guideline recommendations for when to pursue ESR1 mutation testing mutations in patients with HR-positive/HER2-negative advanced breast cancer
Choice and sequencing of next line of systemic therapy for ESR1-mutated advanced breast…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.